Both studies were presented at the American College of Rheumatology (ACR) annual meeting.

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...

While many people living with chronic pain require medication, there is growing interest in non-pharmacological approaches ...

Treatments for hair regrowth include medicated formulas, supplements, lasers, and complementary remedies, such as massage and ...

Dr. Mark Hawass, the trailblazing founder of Arthritis VIP, has been honoured with an esteemed ‘Impact Award’ from Big ...

Sooner or later, it’s inevitable that your knees, back, neck, fingers, or other areas of your body are probably going to feel ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers.

One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

Sixty-nine-year-old Mary Anne Laporte was diagnosed with knee arthritis 15 years ago. For years, she kept the pain under control with steroid injections and physical therapy, but when she began ...

Among patients with rheumatoid arthritis, JAK inhibitors were slightly more effective for reducing pain at 3 and 12 months when compared with TNF inhibitors.